Ubiquitination and proteasomal degradation lead to STAT1 downregulation in several cancer types 20, and western blotting revealed dramatic dose-dependent increase in the STAT1 protein levels after MG132 treatment (Figure S6B). The gene discussed is STAT1; the disease is cancer.